Very cheap Sp at this level, page-8

"But out of 200 or so patients it would appear that not a single one was down-staged to have surgical resection or transplant"

I thought that was odd too, since it seems to be a major benefit of using SIRT in some prior studies. No comment as far as I could see. SIRveNIB will hopefully deal with this, might still get a better OS with SIRT if this approach is taken. Let's say they could achieve a 10% downstage or transplant rate vs 0% with SOR. That would be a major plus in shifting SIRT to 1st line.